这是一篇来自已证抗体库的有关人类 IL-4 (IL-4) 的综述,是根据66篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合IL-4 抗体。
IL-4 同义词: BCGF-1; BCGF1; BSF-1; BSF1; IL-4

其他
  • 流式细胞仪; 人类; 图 7b
IL-4抗体(Biolegend, 8D4-8)被用于被用于流式细胞仪在人类样本上 (图 7b). Front Pharmacol (2019) ncbi
BioLegend
大鼠 单克隆(MP4-25D2)
  • mass cytometry; 人类; 图 s1a
BioLegendIL-4抗体(Biolegend, MP4-25D2)被用于被用于mass cytometry在人类样本上 (图 s1a). Acta Neuropathol (2021) ncbi
大鼠 单克隆(MP4-25D2)
  • 流式细胞仪; 人类; 图 s6d
BioLegendIL-4抗体(Biolegend, 500824)被用于被用于流式细胞仪在人类样本上 (图 s6d). Cell (2021) ncbi
大鼠 单克隆(MP4-25D2)
  • 流式细胞仪; 小鼠; 图 5a
BioLegendIL-4抗体(BioLegend, MP4-25D2)被用于被用于流式细胞仪在小鼠样本上 (图 5a). Science (2019) ncbi
小鼠 单克隆(8D4-8)
  • 流式细胞仪; 人类; 图 1b
BioLegendIL-4抗体(BioLegend, 8D4-8)被用于被用于流式细胞仪在人类样本上 (图 1b). J Immunol (2019) ncbi
大鼠 单克隆(MP4-25D2)
  • 流式细胞仪; 人类; 图 1e
BioLegendIL-4抗体(BioLegend, 500828)被用于被用于流式细胞仪在人类样本上 (图 1e). Cell (2019) ncbi
小鼠 单克隆(8D4-8)
  • 流式细胞仪; 人类; 图 7b
BioLegendIL-4抗体(Biolegend, 8D4-8)被用于被用于流式细胞仪在人类样本上 (图 7b). Front Pharmacol (2019) ncbi
大鼠 单克隆(MP4-25D2)
  • 流式细胞仪; 人类; 表 1
BioLegendIL-4抗体(Biolegend, MP4-25D2)被用于被用于流式细胞仪在人类样本上 (表 1). Cytometry A (2017) ncbi
大鼠 单克隆(MP4-25D2)
  • 抑制或激活实验; 人类
BioLegendIL-4抗体(BioLegend, MP4-25D2)被用于被用于抑制或激活实验在人类样本上. Eur J Immunol (2016) ncbi
小鼠 单克隆(8D4-8)
  • 流式细胞仪; 人类
BioLegendIL-4抗体(BioLegend, 8D4-8)被用于被用于流式细胞仪在人类样本上. Thromb Res (2015) ncbi
大鼠 单克隆(MP4-25D2)
  • 流式细胞仪; 人类; 2 ul/test
BioLegendIL-4抗体(Biolegend, MP4-25D2)被用于被用于流式细胞仪在人类样本上浓度为2 ul/test. J Immunol Methods (2015) ncbi
大鼠 单克隆(MP4-25D2)
  • dot blot; 人类; 表 s1
BioLegendIL-4抗体(Biolegend, 500802)被用于被用于dot blot在人类样本上 (表 s1). Proc Natl Acad Sci U S A (2015) ncbi
小鼠 单克隆(8D4-8)
  • dot blot; 人类; 表 s1
BioLegendIL-4抗体(Biolegend, 500702)被用于被用于dot blot在人类样本上 (表 s1). Proc Natl Acad Sci U S A (2015) ncbi
大鼠 单克隆(MP4-25D2)
  • 免疫细胞化学; 人类
BioLegendIL-4抗体(BioLegend, MP4-25D2)被用于被用于免疫细胞化学在人类样本上. J Immunol (2014) ncbi
大鼠 单克隆(MP4-25D2)
  • 流式细胞仪; 人类
BioLegendIL-4抗体(Biolegend, MP4-25D2)被用于被用于流式细胞仪在人类样本上. Med Microbiol Immunol (2014) ncbi
大鼠 单克隆(MP4-25D2)
BioLegendIL-4抗体(BioLegend, MP4-25D2)被用于. J Immunol (2014) ncbi
赛默飞世尔
小鼠 单克隆(E10023)
  • 酶联免疫吸附测定; 人类; 1.5 ug/ml; 图 6b
赛默飞世尔IL-4抗体(Endogen, E10023)被用于被用于酶联免疫吸附测定在人类样本上浓度为1.5 ug/ml (图 6b). Clin Immunol (2017) ncbi
小鼠 单克隆(E10021)
  • 酶联免疫吸附测定; 人类; 图 6b
赛默飞世尔IL-4抗体(Endogen, E10021)被用于被用于酶联免疫吸附测定在人类样本上 (图 6b). Clin Immunol (2017) ncbi
小鼠 单克隆(8D4-8)
  • 流式细胞仪; 人类; 图 4b
赛默飞世尔IL-4抗体(eBioscience, 12-7049-42)被用于被用于流式细胞仪在人类样本上 (图 4b). Front Immunol (2016) ncbi
domestic rabbit 多克隆
  • 免疫组化-石蜡切片; 小鼠; 图 4d
赛默飞世尔IL-4抗体(Thermo Fisher Scientific, PA5-25165)被用于被用于免疫组化-石蜡切片在小鼠样本上 (图 4d). Cell Death Dis (2016) ncbi
小鼠 单克隆(8D4-8)
  • 流式细胞仪; 人类; 图 8d
赛默飞世尔IL-4抗体(eBiosciences, 8D4-8)被用于被用于流式细胞仪在人类样本上 (图 8d). Nat Immunol (2016) ncbi
小鼠 单克隆(8D4-8)
  • 流式细胞仪; 人类; 图 2a
赛默飞世尔IL-4抗体(eBioscience, 8D4-8)被用于被用于流式细胞仪在人类样本上 (图 2a). PLoS Pathog (2016) ncbi
小鼠 单克隆(8D4-8)
  • 流式细胞仪; 人类
赛默飞世尔IL-4抗体(Ebioscience, 8D4-8)被用于被用于流式细胞仪在人类样本上. Clin Immunol (2015) ncbi
小鼠 单克隆(8D4-8)
  • 免疫细胞化学; 人类
赛默飞世尔IL-4抗体(eBioscience, 8D4-8)被用于被用于免疫细胞化学在人类样本上. Autoimmun Rev (2015) ncbi
小鼠 单克隆(8D4-8)
  • 流式细胞仪; 人类
赛默飞世尔IL-4抗体(eBioscience, 8D4-8)被用于被用于流式细胞仪在人类样本上. J Allergy Clin Immunol (2015) ncbi
小鼠 单克隆(8D4-8)
  • 流式细胞仪; 人类
赛默飞世尔IL-4抗体(eBioscience, 8D48)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2014) ncbi
大鼠 单克隆(MP4-25D2)
  • 抑制或激活实验; 人类; 10 ug/ml
赛默飞世尔IL-4抗体(eBioscience, MP4-25D2)被用于被用于抑制或激活实验在人类样本上浓度为10 ug/ml. PLoS ONE (2014) ncbi
大鼠 单克隆(MP4-25D2)
  • 流式细胞仪; 人类; 图 7b
赛默飞世尔IL-4抗体(Invitrogen Dynal AS, MP425D2)被用于被用于流式细胞仪在人类样本上 (图 7b). J Leukoc Biol (2014) ncbi
大鼠 单克隆(MP4-25D2)
  • 流式细胞仪; 人类
赛默飞世尔IL-4抗体(eBioscience, MP4-25D2)被用于被用于流式细胞仪在人类样本上. Immun Ageing (2013) ncbi
大鼠 单克隆(25D2)
  • 流式细胞仪; 人类; 1:50
赛默飞世尔IL-4抗体(Invitrogen, MP4-25D2)被用于被用于流式细胞仪在人类样本上浓度为1:50. PLoS ONE (2012) ncbi
小鼠 单克隆(860A4B3)
  • 抑制或激活实验; 人类; 5 ug/ml
赛默飞世尔IL-4抗体(Invitrogen, 4B3)被用于被用于抑制或激活实验在人类样本上浓度为5 ug/ml. Immunol Lett (2011) ncbi
大鼠 单克隆(MP4-25D2)
  • 流式细胞仪; 人类; 图 1C
赛默飞世尔IL-4抗体(e-Bioscience, MP4-25D2)被用于被用于流式细胞仪在人类样本上 (图 1C). Ann Rheum Dis (2008) ncbi
大鼠 单克隆(25D2)
  • 免疫细胞化学; 人类
赛默飞世尔IL-4抗体(Caltag, MP4-25D2)被用于被用于免疫细胞化学在人类样本上. J Virol (2007) ncbi
大鼠 单克隆(MP4-25D2)
  • 抑制或激活实验; 人类; 5 ug/ml
赛默飞世尔IL-4抗体(eBioscience, MP4-25D2)被用于被用于抑制或激活实验在人类样本上浓度为5 ug/ml. Blood (2007) ncbi
小鼠 单克隆(860A4B3)
  • 酶联免疫吸附测定; 人类
赛默飞世尔IL-4抗体(Biosource, 860A4B3)被用于被用于酶联免疫吸附测定在人类样本上. Immunology (2006) ncbi
大鼠 单克隆(25D2)
  • 流式细胞仪; 人类; 表 2
赛默飞世尔IL-4抗体(Caltag, MP4-25D2)被用于被用于流式细胞仪在人类样本上 (表 2). Eur J Immunol (2005) ncbi
大鼠 单克隆(25D2)
  • 流式细胞仪; 人类; 图 2
赛默飞世尔IL-4抗体(Caltag, MP4-25D2)被用于被用于流式细胞仪在人类样本上 (图 2). J Immunol (2005) ncbi
小鼠 单克隆(860A4B3)
  • 酶联免疫吸附测定; 人类; 1 ug/ml; 表 1
赛默飞世尔IL-4抗体(Biosource, 860A4B3)被用于被用于酶联免疫吸附测定在人类样本上浓度为1 ug/ml (表 1). J Leukoc Biol (2004) ncbi
小鼠 单克隆(860A4B3)
  • 流式细胞仪; 猕猴; 图 4, 5
赛默飞世尔IL-4抗体(Biosource, 860A 4B3)被用于被用于流式细胞仪在猕猴样本上 (图 4, 5). J Immunol (2003) ncbi
大鼠 单克隆(25D2)
  • 流式细胞仪; 人类; 图 5
赛默飞世尔IL-4抗体(Caltag, MP4-25D2)被用于被用于流式细胞仪在人类样本上 (图 5). J Rheumatol (2003) ncbi
小鼠 单克隆(860A4B3)
  • 流式细胞仪; 人类; 图 1
赛默飞世尔IL-4抗体(BioSource, 4B3)被用于被用于流式细胞仪在人类样本上 (图 1). J Immunol (2002) ncbi
小鼠 单克隆(860A4B3)
  • 酶联免疫吸附测定; 人类; 图 2, 3
赛默飞世尔IL-4抗体(Biosource, 860A4B3)被用于被用于酶联免疫吸附测定在人类样本上 (图 2, 3). Int Immunol (2001) ncbi
小鼠 单克隆(860F10H12)
  • 酶联免疫吸附测定; 人类; 图 2, 3
赛默飞世尔IL-4抗体(Biosource, 860F10H12)被用于被用于酶联免疫吸附测定在人类样本上 (图 2, 3). Int Immunol (2001) ncbi
艾博抗(上海)贸易有限公司
domestic rabbit 多克隆
  • 免疫印迹; 大鼠; 1:500; 图 s1b
艾博抗(上海)贸易有限公司IL-4抗体(Abcam, ab9622)被用于被用于免疫印迹在大鼠样本上浓度为1:500 (图 s1b). J Allergy Clin Immunol (2017) ncbi
domestic rabbit 多克隆
  • 免疫组化; 小鼠; 1:100; 图 4
艾博抗(上海)贸易有限公司IL-4抗体(abcam, ab9622)被用于被用于免疫组化在小鼠样本上浓度为1:100 (图 4). J Neuroinflammation (2016) ncbi
domestic rabbit 多克隆
  • 免疫组化; 人类; 1:200; 图 4
艾博抗(上海)贸易有限公司IL-4抗体(Abcam, ab9622)被用于被用于免疫组化在人类样本上浓度为1:200 (图 4). Arch Med Sci (2016) ncbi
贝克曼库尔特实验系统(苏州)有限公司
小鼠 单克隆(4D9)
  • 流式细胞仪; 人类; 图 1
贝克曼库尔特实验系统(苏州)有限公司IL-4抗体(Beckman Coulter, IM2719U)被用于被用于流式细胞仪在人类样本上 (图 1). Exp Ther Med (2017) ncbi
赛信通(上海)生物试剂有限公司
domestic rabbit 单克隆(D19A10)
  • 免疫印迹; 人类; 1:1000; 图 3b
赛信通(上海)生物试剂有限公司IL-4抗体(Cell Signaling, D19A10)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 3b). PLoS ONE (2018) ncbi
碧迪BD
小鼠 单克隆(8D4-8)
  • 流式细胞仪; 小鼠; 图 4
碧迪BDIL-4抗体(BD, 8D4-8)被用于被用于流式细胞仪在小鼠样本上 (图 4). BMC Infect Dis (2019) ncbi
大鼠 单克隆(MP4-25D2)
  • 抑制或激活实验; 人类; 10 ng/ml; 图 6a
碧迪BDIL-4抗体(BD Biosciences, 554481)被用于被用于抑制或激活实验在人类样本上浓度为10 ng/ml (图 6a). elife (2019) ncbi
大鼠 单克隆(MP4-25D2)
  • 流式细胞仪; 人类; 图 3b
碧迪BDIL-4抗体(BD, MP4-25D2)被用于被用于流式细胞仪在人类样本上 (图 3b). Infect Immun (2019) ncbi
大鼠 单克隆(MP4-25D2)
  • 流式细胞仪; 人类; 图 s3b
碧迪BDIL-4抗体(BD Biosciences, MP4-25D2)被用于被用于流式细胞仪在人类样本上 (图 s3b). Int J Hematol (2018) ncbi
小鼠 单克隆(8D4-8)
  • 流式细胞仪; 人类; 图 1e
碧迪BDIL-4抗体(BD Biosciences, 8D4-8)被用于被用于流式细胞仪在人类样本上 (图 1e). J Immunol (2018) ncbi
大鼠 单克隆(MP4-25D2)
  • 流式细胞仪; 人类; 表 1
碧迪BDIL-4抗体(BD Biosciences, 554484)被用于被用于流式细胞仪在人类样本上 (表 1). J Clin Invest (2018) ncbi
小鼠 (8D4-8)
  • 流式细胞仪; 人类; 图 6a
碧迪BDIL-4抗体(BD Bioscience, 8D4-8)被用于被用于流式细胞仪在人类样本上 (图 6a). PLoS ONE (2017) ncbi
小鼠 单克隆(8D4-8)
  • 流式细胞仪; 猕猴; 图 5a
碧迪BDIL-4抗体(BD Biosciences, 8D4-8)被用于被用于流式细胞仪在猕猴样本上 (图 5a). JCI Insight (2017) ncbi
大鼠 单克隆(MP4-25D2)
  • 流式细胞仪; 人类; 表 s9
碧迪BDIL-4抗体(BD, 564110)被用于被用于流式细胞仪在人类样本上 (表 s9). Nature (2017) ncbi
小鼠 单克隆(8D4-8)
  • 流式细胞仪; 人类; 图 s2b
碧迪BDIL-4抗体(BD Biosciences, 8D4-8)被用于被用于流式细胞仪在人类样本上 (图 s2b). J Immunol (2016) ncbi
大鼠 单克隆(MP4-25D2)
  • 抑制或激活实验; 人类; 12.5 mg/ml; 图 s3c
碧迪BDIL-4抗体(BD Biosciences, 554481)被用于被用于抑制或激活实验在人类样本上浓度为12.5 mg/ml (图 s3c). Cell (2016) ncbi
小鼠 单克隆(8D4-8)
  • 流式细胞仪; 人类
碧迪BDIL-4抗体(BD, 8D4-8)被用于被用于流式细胞仪在人类样本上. J Immunol (2016) ncbi
小鼠 单克隆(8D4-8)
  • 流式细胞仪; 人类; 图 3d
碧迪BDIL-4抗体(BD Pharmingen, 8D4-8)被用于被用于流式细胞仪在人类样本上 (图 3d). PLoS ONE (2016) ncbi
小鼠 单克隆(8D4-8)
  • 流式细胞仪; 人类; 图 8
碧迪BDIL-4抗体(BD, 561234)被用于被用于流式细胞仪在人类样本上 (图 8). Nat Commun (2015) ncbi
大鼠 单克隆(MP4-25D2)
  • 流式细胞仪; 人类; 1:200; 图 5
碧迪BDIL-4抗体(BD Biosciences, 554486)被用于被用于流式细胞仪在人类样本上浓度为1:200 (图 5). Nat Commun (2015) ncbi
大鼠 单克隆(MP4-25D2)
  • 流式细胞仪; 人类; 4:100; 图 3a
碧迪BDIL-4抗体(Becton Dickinson, MP4-25D2)被用于被用于流式细胞仪在人类样本上浓度为4:100 (图 3a). Nat Commun (2015) ncbi
小鼠 单克隆(8D4-8)
  • 流式细胞仪; 人类
碧迪BDIL-4抗体(BD Pharmingen, 8D4-8)被用于被用于流式细胞仪在人类样本上. Chest (2015) ncbi
小鼠 单克隆(3010.211)
  • 流式细胞仪; 人类
碧迪BDIL-4抗体(BD, 3010.211)被用于被用于流式细胞仪在人类样本上. Nat Immunol (2015) ncbi
小鼠 单克隆(8D4-8)
  • 流式细胞仪; 人类; 图 5
碧迪BDIL-4抗体(BD Biosciences, 8D4-8)被用于被用于流式细胞仪在人类样本上 (图 5). Nat Immunol (2014) ncbi
小鼠 单克隆(8D4-8)
  • 流式细胞仪; 人类
碧迪BDIL-4抗体(BD Pharmingen, 8D4-8)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2014) ncbi
小鼠 单克隆(3010.211)
  • 流式细胞仪; 人类
碧迪BDIL-4抗体(BD, 3010.211)被用于被用于流式细胞仪在人类样本上. J Exp Med (2014) ncbi
小鼠 单克隆(8D4-8)
  • 流式细胞仪; 人类
碧迪BDIL-4抗体(BD Pharmigen, 8D4-8)被用于被用于流式细胞仪在人类样本上. J Cell Physiol (2014) ncbi
文章列表
  1. Ingelfinger F, Krishnarajah S, Kramer M, Utz S, Galli E, Lutz M, et al. Single-cell profiling of myasthenia gravis identifies a pathogenic T cell signature. Acta Neuropathol. 2021;141:901-915 pubmed 出版商
  2. Rodda L, Netland J, Shehata L, Pruner K, Morawski P, Thouvenel C, et al. Functional SARS-CoV-2-Specific Immune Memory Persists after Mild COVID-19. Cell. 2021;184:169-183.e17 pubmed 出版商
  3. Zhao Y, Yang Q, Jin C, Feng Y, Xie S, Xie H, et al. Changes of CD103-expressing pulmonary CD4+ and CD8+ T cells in S. japonicum infected C57BL/6 mice. BMC Infect Dis. 2019;19:999 pubmed 出版商
  4. Martínez Fábregas J, Wilmes S, Wang L, Hafer M, Pohler E, Lokau J, et al. Kinetics of cytokine receptor trafficking determine signaling and functional selectivity. elife. 2019;8: pubmed 出版商
  5. Gowthaman U, Chen J, Zhang B, Flynn W, Lu Y, Song W, et al. Identification of a T follicular helper cell subset that drives anaphylactic IgE. Science. 2019;365: pubmed 出版商
  6. Meckiff B, Ladell K, McLaren J, Ryan G, Leese A, James E, et al. Primary EBV Infection Induces an Acute Wave of Activated Antigen-Specific Cytotoxic CD4+ T Cells. J Immunol. 2019;203:1276-1287 pubmed 出版商
  7. van de Garde M, van Westen E, Poelen M, Rots N, van Els C. Prediction and Validation of Immunogenic Domains of Pneumococcal Proteins Recognized by Human CD4+ T Cells. Infect Immun. 2019;87: pubmed 出版商
  8. Bacher P, Hohnstein T, Beerbaum E, Röcker M, Blango M, Kaufmann S, et al. Human Anti-fungal Th17 Immunity and Pathology Rely on Cross-Reactivity against Candida albicans. Cell. 2019;: pubmed 出版商
  9. Lichnog C, Klabunde S, Becker E, Fuh F, Tripal P, Atreya R, et al. Cellular Mechanisms of Etrolizumab Treatment in Inflammatory Bowel Disease. Front Pharmacol. 2019;10:39 pubmed 出版商
  10. Watanabe N, Takaku T, Takeda K, Shirane S, Toyota T, Koike M, et al. Dasatinib-induced anti-leukemia cellular immunity through a novel subset of CD57 positive helper/cytotoxic CD4 T cells in chronic myelogenous leukemia patients. Int J Hematol. 2018;108:588-597 pubmed 出版商
  11. Walwyn Brown K, Guldevall K, Saeed M, Pende D, Önfelt B, MacDonald A, et al. Human NK Cells Lyse Th2-Polarizing Dendritic Cells via NKp30 and DNAM-1. J Immunol. 2018;201:2028-2041 pubmed 出版商
  12. D Addio F, Vergani A, Potena L, Maestroni A, Usuelli V, Ben Nasr M, et al. P2X7R mutation disrupts the NLRP3-mediated Th program and predicts poor cardiac allograft outcomes. J Clin Invest. 2018;128:3490-3503 pubmed 出版商
  13. Vargas D, Lopez C, Acero E, Benítez E, Wintaco A, Camacho J, et al. Thermogenic capacity of human periaortic adipose tissue is transformed by body weight. PLoS ONE. 2018;13:e0194269 pubmed 出版商
  14. Jeffery H, McDowell P, Lutz P, Wawman R, Roberts S, Bagnall C, et al. Human intrahepatic ILC2 are IL-13positive amphiregulinpositive and their frequency correlates with model of end stage liver disease score. PLoS ONE. 2017;12:e0188649 pubmed 出版商
  15. Chen C, Sun W, Chen J, Huang J. Dynamic variations of the peripheral blood immune cell subpopulation in patients with critical H7N9 swine-origin influenza A virus infection: A retrospective small-scale study. Exp Ther Med. 2017;13:1490-1494 pubmed 出版商
  16. Dowling D, van Haren S, Scheid A, Bergelson I, Kim D, Mancuso C, et al. TLR7/8 adjuvant overcomes newborn hyporesponsiveness to pneumococcal conjugate vaccine at birth. JCI Insight. 2017;2:e91020 pubmed 出版商
  17. Mordmuller B, Surat G, Lagler H, Chakravarty S, Ishizuka A, Lalremruata A, et al. Sterile protection against human malaria by chemoattenuated PfSPZ vaccine. Nature. 2017;542:445-449 pubmed 出版商
  18. Mufarrege E, Giorgetti S, Etcheverrigaray M, Terry F, Martin W, De Groot A. De-immunized and Functional Therapeutic (DeFT) versions of a long lasting recombinant alpha interferon for antiviral therapy. Clin Immunol. 2017;176:31-41 pubmed 出版商
  19. Zhu H, Hu F, Sun X, Zhang X, Zhu L, Liu X, et al. CD16+ Monocyte Subset Was Enriched and Functionally Exacerbated in Driving T-Cell Activation and B-Cell Response in Systemic Lupus Erythematosus. Front Immunol. 2016;7:512 pubmed
  20. Naeem A, Tommasi C, Cole C, Brown S, Zhu Y, Way B, et al. A mechanistic target of rapamycin complex 1/2 (mTORC1)/V-Akt murine thymoma viral oncogene homolog 1 (AKT1)/cathepsin H axis controls filaggrin expression and processing in skin, a novel mechanism for skin barrier disruption in patients with atopic d. J Allergy Clin Immunol. 2017;139:1228-1241 pubmed 出版商
  21. Jiang X, Zha B, Liu X, Liu R, Liu J, Huang E, et al. STAT6 deficiency ameliorates Graves' disease severity by suppressing thyroid epithelial cell hyperplasia. Cell Death Dis. 2016;7:e2506 pubmed 出版商
  22. Sumatoh H, Teng K, Cheng Y, Newell E. Optimization of mass cytometry sample cryopreservation after staining. Cytometry A. 2017;91:48-61 pubmed 出版商
  23. van Haren S, Dowling D, Foppen W, Christensen D, Andersen P, Reed S, et al. Age-Specific Adjuvant Synergy: Dual TLR7/8 and Mincle Activation of Human Newborn Dendritic Cells Enables Th1 Polarization. J Immunol. 2016;197:4413-4424 pubmed
  24. Roybal K, Williams J, Morsut L, Rupp L, Kolinko I, Choe J, et al. Engineering T Cells with Customized Therapeutic Response Programs Using Synthetic Notch Receptors. Cell. 2016;167:419-432.e16 pubmed 出版商
  25. Neumann L, Mueller M, Moos V, Heller F, Meyer T, Loddenkemper C, et al. Mucosal Inducible NO Synthase-Producing IgA+ Plasma Cells in Helicobacter pylori-Infected Patients. J Immunol. 2016;197:1801-8 pubmed 出版商
  26. Lee K, Lee H, Lin H, Tsay H, Tsai F, Shyue S, et al. Role of transient receptor potential ankyrin 1 channels in Alzheimer's disease. J Neuroinflammation. 2016;13:92 pubmed 出版商
  27. Bal S, Bernink J, Nagasawa M, Groot J, Shikhagaie M, Golebski K, et al. IL-1?, IL-4 and IL-12 control the fate of group 2 innate lymphoid cells in human airway inflammation in the lungs. Nat Immunol. 2016;17:636-45 pubmed 出版商
  28. Szylberg Å, Janiczek M, Popiel A, MarszaÅ‚ek A. Expression of COX-2, IL-1β, TNF-α and IL-4 in epithelium of serrated adenoma, adenoma and hyperplastic polyp. Arch Med Sci. 2016;12:172-8 pubmed 出版商
  29. James E, Gates T, LaFond R, Yamamoto S, Ni C, Mai D, et al. Neuroinvasive West Nile Infection Elicits Elevated and Atypically Polarized T Cell Responses That Promote a Pathogenic Outcome. PLoS Pathog. 2016;12:e1005375 pubmed 出版商
  30. Li L, Jiang Y, Lao S, Yang B, Yu S, Zhang Y, et al. Mycobacterium tuberculosis-Specific IL-21+IFN-γ+CD4+ T Cells Are Regulated by IL-12. PLoS ONE. 2016;11:e0147356 pubmed 出版商
  31. Kobayashi S, Watanabe T, Suzuki R, Furu M, Ito H, Ito J, et al. TGF-β induces the differentiation of human CXCL13-producing CD4(+) T cells. Eur J Immunol. 2016;46:360-71 pubmed 出版商
  32. Miles B, Miller S, Folkvord J, Kimball A, Chamanian M, Meditz A, et al. Follicular regulatory T cells impair follicular T helper cells in HIV and SIV infection. Nat Commun. 2015;6:8608 pubmed 出版商
  33. Zhu F, Qiao J, Cao J, Sun H, Wu Q, Sun Z, et al. Decreased level of cytotoxic T lymphocyte antigen-4 (CTLA-4) in patients with acute immune thrombocytopenia (ITP). Thromb Res. 2015;136:797-802 pubmed 出版商
  34. Lee J, Jeong I, Joh J, Jung Y, Sim S, Choi B, et al. Differential expression of CD57 in antigen-reactive CD4+ T cells between active and latent tuberculosis infection. Clin Immunol. 2015;159:37-46 pubmed 出版商
  35. Spurlock C, Tossberg J, Guo Y, Collier S, Crooke P, Aune T. Expression and functions of long noncoding RNAs during human T helper cell differentiation. Nat Commun. 2015;6:6932 pubmed 出版商
  36. Hong M, Sandalova E, Low D, Gehring A, Fieni S, Amadei B, et al. Trained immunity in newborn infants of HBV-infected mothers. Nat Commun. 2015;6:6588 pubmed 出版商
  37. Bowcutt R, Malter L, Chen L, Wolff M, Robertson I, Rifkin D, et al. Isolation and cytokine analysis of lamina propria lymphocytes from mucosal biopsies of the human colon. J Immunol Methods. 2015;421:27-35 pubmed 出版商
  38. Lu Y, Xue Q, Eisele M, Sulistijo E, Brower K, Han L, et al. Highly multiplexed profiling of single-cell effector functions reveals deep functional heterogeneity in response to pathogenic ligands. Proc Natl Acad Sci U S A. 2015;112:E607-15 pubmed 出版商
  39. Touzot M, Cacoub P, Bodaghi B, Soumelis V, Saadoun D. IFN-α induces IL-10 production and tilt the balance between Th1 and Th17 in Behçet disease. Autoimmun Rev. 2015;14:370-5 pubmed 出版商
  40. Van Eyck L, Hershfield M, Pombal D, Kelly S, Ganson N, Moens L, et al. Hematopoietic stem cell transplantation rescues the immunologic phenotype and prevents vasculopathy in patients with adenosine deaminase 2 deficiency. J Allergy Clin Immunol. 2015;135:283-7.e5 pubmed 出版商
  41. Hautefort A, Girerd B, Montani D, Cohen Kaminsky S, Price L, Lambrecht B, et al. T-helper 17 cell polarization in pulmonary arterial hypertension. Chest. 2015;147:1610-1620 pubmed 出版商
  42. Dominguez Villar M, Gautron A, de Marcken M, Keller M, Hafler D. TLR7 induces anergy in human CD4(+) T cells. Nat Immunol. 2015;16:118-28 pubmed 出版商
  43. Kamburova E, Koenen H, van den Hoogen M, Baas M, Joosten I, Hilbrands L. Longitudinal analysis of T and B cell phenotype and function in renal transplant recipients with or without rituximab induction therapy. PLoS ONE. 2014;9:e112658 pubmed 出版商
  44. Simpson L, Patel S, Bhakta N, Choy D, Brightbill H, Ren X, et al. A microRNA upregulated in asthma airway T cells promotes TH2 cytokine production. Nat Immunol. 2014;15:1162-70 pubmed 出版商
  45. Cucak H, Vistisen D, Witte D, Philipsen A, Rosendahl A. Reduction of specific circulating lymphocyte populations with metabolic risk factors in patients at risk to develop type 2 diabetes. PLoS ONE. 2014;9:e107140 pubmed 出版商
  46. Yu C, Becker C, Metang P, Marches F, Wang Y, Toshiyuki H, et al. Human CD141+ dendritic cells induce CD4+ T cells to produce type 2 cytokines. J Immunol. 2014;193:4335-43 pubmed 出版商
  47. Weist B, Schmueck M, Fuehrer H, Sattler A, Reinke P, Babel N. The role of CD4(+) T cells in BKV-specific T cell immunity. Med Microbiol Immunol. 2014;203:395-408 pubmed 出版商
  48. Staumont Sallé D, Fleury S, Lazzari A, Molendi Coste O, Hornez N, Lavogiez C, et al. CX?CL1 (fractalkine) and its receptor CX?CR1 regulate atopic dermatitis by controlling effector T cell retention in inflamed skin. J Exp Med. 2014;211:1185-96 pubmed 出版商
  49. Deng N, Weaver J, Mosmann T. Cytokine diversity in the Th1-dominated human anti-influenza response caused by variable cytokine expression by Th1 cells, and a minor population of uncommitted IL-2+IFN?- Thpp cells. PLoS ONE. 2014;9:e95986 pubmed 出版商
  50. Hebel K, Weinert S, Kuropka B, Knolle J, Kosak B, Jorch G, et al. CD4+ T cells from human neonates and infants are poised spontaneously to run a nonclassical IL-4 program. J Immunol. 2014;192:5160-70 pubmed 出版商
  51. Galindo Albarrán A, Ramirez Pliego O, Labastida Conde R, Melchy Pérez E, Liquitaya Montiel A, Esquivel Guadarrama F, et al. CD43 signals prepare human T cells to receive cytokine differentiation signals. J Cell Physiol. 2014;229:172-80 pubmed
  52. Svajger U, Obermajer N, Jeras M. IFN-?-rich environment programs dendritic cells toward silencing of cytotoxic immune responses. J Leukoc Biol. 2014;95:33-46 pubmed 出版商
  53. Gironi M, Saresella M, Rovaris M, Vaghi M, Nemni R, Clerici M, et al. A novel data mining system points out hidden relationships between immunological markers in multiple sclerosis. Immun Ageing. 2013;10:1 pubmed 出版商
  54. Wolff M, Leung J, Davenport M, Poles M, Cho I, Loke P. TH17, TH22 and Treg cells are enriched in the healthy human cecum. PLoS ONE. 2012;7:e41373 pubmed 出版商
  55. Chen M, Tsai T, Lin Y, Tsai Y, Wang L, Lee M, et al. Antipsychotic drugs suppress the AKT/NF-?B pathway and regulate the differentiation of T-cell subsets. Immunol Lett. 2011;140:81-91 pubmed 出版商
  56. Yamada H, Nakashima Y, Okazaki K, Mawatari T, Fukushi J, Kaibara N, et al. Th1 but not Th17 cells predominate in the joints of patients with rheumatoid arthritis. Ann Rheum Dis. 2008;67:1299-304 pubmed
  57. Kueng H, Leb V, Haiderer D, Raposo G, Thery C, Derdak S, et al. General strategy for decoration of enveloped viruses with functionally active lipid-modified cytokines. J Virol. 2007;81:8666-76 pubmed
  58. De Fanis U, Mori F, Kurnat R, Lee W, Bova M, Adkinson N, et al. GATA3 up-regulation associated with surface expression of CD294/CRTH2: a unique feature of human Th cells. Blood. 2007;109:4343-50 pubmed
  59. Janke M, Witsch E, Mages H, Hutloff A, Kroczek R. Eminent role of ICOS costimulation for T cells interacting with plasmacytoid dendritic cells. Immunology. 2006;118:353-60 pubmed
  60. Bratke K, Kuepper M, Bade B, Virchow J, Luttmann W. Differential expression of human granzymes A, B, and K in natural killer cells and during CD8+ T cell differentiation in peripheral blood. Eur J Immunol. 2005;35:2608-16 pubmed
  61. Kirchberger S, Majdic O, Steinberger P, Bluml S, Pfistershammer K, Zlabinger G, et al. Human rhinoviruses inhibit the accessory function of dendritic cells by inducing sialoadhesin and B7-H1 expression. J Immunol. 2005;175:1145-52 pubmed
  62. Kooijman R, Coppens A. Insulin-like growth factor-I stimulates IL-10 production in human T cells. J Leukoc Biol. 2004;76:862-7 pubmed
  63. Gansuvd B, Hubbard W, Hutchings A, Thomas F, Goodwin J, Wilson S, et al. Phenotypic and functional characterization of long-term cultured rhesus macaque spleen-derived NKT cells. J Immunol. 2003;171:2904-11 pubmed
  64. Hatachi S, Iwai Y, Kawano S, Morinobu S, Kobayashi M, Koshiba M, et al. CD4+ PD-1+ T cells accumulate as unique anergic cells in rheumatoid arthritis synovial fluid. J Rheumatol. 2003;30:1410-9 pubmed
  65. Cousins D, Lee T, Staynov D. Cytokine coexpression during human Th1/Th2 cell differentiation: direct evidence for coordinated expression of Th2 cytokines. J Immunol. 2002;169:2498-506 pubmed
  66. Bullens D, Rafiq K, Charitidou L, Peng X, Kasran A, Warmerdam P, et al. Effects of co-stimulation by CD58 on human T cell cytokine production: a selective cytokine pattern with induction of high IL-10 production. Int Immunol. 2001;13:181-91 pubmed